Oligomerix
Signal active
Organization
Contact Information
Overview
Oligomerix is a biopharmaceutical company founded in 2006 by co-founders Eliot J. Davidowitz and James Moe. The Company is exploiting its novel research that allows rapid generation of stable amyloid oligomers as targets for drug discovery. These systems will enable target identification and validation, and drug discovery for Alzheimer's and other neurodegenerative diseases.
About
Industries
Biotechnology, Medical, Ediscovery
Founded
2006
Employees
1-10
Headquarters locations
Bronx, New York, United States, North America
Social
Profile Resume
Oligomerix headquartered in New York, United States, North America, operates in the Biotechnology, Medical, Ediscovery sector. The company focuses on Biotechnology and has secured $1.7B in funding across 96 round(s). With a team of 1-10 employees, Oligomerix is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Oligomerix, raised $2.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
8
Investors
3
Lead Investors
0
Total Funding Amount
$17.6M
Details
3
Oligomerix has raised a total of $17.6M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Early Stage Venture | 2.7M | ||
| 2013 | Early Stage Venture | 2.8M | ||
| 2012 | Early Stage Venture | 2.0M |
Investors
Oligomerix is funded by 10 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Durand Venture Associates | - | FUNDING ROUND - Durand Venture Associates | 2.0M |
| Wheatley Partners | - | FUNDING ROUND - Wheatley Partners | 2.0M |
| Oligomerix | - | FUNDING ROUND - Oligomerix | 2.0M |
| Wheatley MedTech Partners | - | FUNDING ROUND - Wheatley MedTech Partners | 2.0M |
Recent Activity
Funding Round
Oct 04, 2022
Oligomerix raised $2490000 on 2022-10-04 in Grant
Funding Round
Aug 09, 2022
Oligomerix raised $3350000 on 2022-08-09 in Grant
Funding Round
Jun 02, 2022
Oligomerix raised $2700000 on 2022-06-02 in Series B
News
Aug 30, 2021
Google Patent - Methods and compositions comprising tau oligomers
Funding Round
Oct 10, 2019
Oligomerix raised $2180000 on 2019-10-10 in Grant
Funding Round
Apr 15, 2015
Oligomerix raised $400000 on 2015-04-15 in Venture Round